US says it will not join global effort to find COVID-19 vaccine

The administration of United States President Donald Trump has said that it will not work with an international cooperative effort to develop and distribute the COVID-19 vaccine, as it is not constrained by multilateral groups such as the World Health Organization (WHO) Wants to be

The decision to go it alone, previously reported by the Washington Post, followed the White House’s decision to pull the US out of the WHO in early July. Trump claims the WHO needs reform and is heavily influenced by China.

Some countries have worked directly to secure vaccine supplies, but others are trying to ensure success against a disease that has no geographic boundaries. More than 150 countries are establishing the COVID-19 vaccine Global Access Facility or COVAX.

This cooperative effort, linked with the WHO, will allow nations to leverage their portfolio of potential vaccines to ensure that their citizens are covered effectively.

The WHO states that even vaccine-making governments would benefit from joining COVAX because it would not provide backup vaccines in cases being carried out through bilateral deals with manufacturers.

COVID-19 vaccine: rush to treat countries as safety concerns

White House spokesman Jude Deere said on Tuesday, “The United States will continue to engage its international partners to defeat the virus, but we will not be constrained by the corrupt World Health Organization and multilateral organizations affected by China.”

“This president will spare no expense to ensure that any new vaccine maintains our own Food and Drug Administration’s gold standard for safety and efficacy, [and] Fully tested and saves lives. ”

As of now, there is no coronovirus vaccine anywhere in the world that has been approved for full use.

Third stage of development

US-based biotechnology company Modern is in the third phase of testing for its vaccine, meaning the vaccine has been approved for early or limited use – the final stage before it becomes available on the market.

The final trial of the government-funded vaccine will involve about 30,000 individuals, but it is unclear when that phase will end.

The United Kingdom company AstraZeneca also said that its vaccine candidate had entered the final testing phase in the US. Another vaccine is being developed jointly by American company Pfizer Inc. and Germany’s Bioentech.

Other countries including Russia, China and Australia said that their vaccines are also in the third stage of development.

Will the Russian COVID-19 vaccine work? | Inside talk

The US has recorded the most COVID-19 cases, numbering more than six million, as well as deaths, close to 185,000.

Trump has repeatedly stated that there may be a coronovirus vaccine in the US before the November 3 presidential election, although none of the vaccines being developed in the US have completed the testing phase in determining the drug’s efficacy is important.

In early August, America’s top infectious disease specialist, Dr. Anthony Fauci said studies on the modern vaccine could produce definitive data in November or December of this year.

But they said that the approved COVID-19 vaccine could only last 50 to 60 percent of the time.

Fauci said the chances of the vaccine being 98 percent effective are “not great.”


Leave a Reply